Serial Number 88516939
Registration 6143195
700

Registration Progress

Application Filed
Jul 16, 2019
Under Examination
Jun 16, 2020
Approved for Publication
Apr 21, 2020
Published for Opposition
Apr 21, 2020
Registered
Sep 1, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200901)
Due: Sep 01, 2026 244 days

Trademark Image

Basic Information

Serial Number
88516939
Registration Number
6143195
Filing Date
July 16, 2019
Registration Date
September 1, 2020
Published for Opposition
April 21, 2020
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 1, 2020
Registration
Registered
Classes
005

Rights Holder

I-MAB BIOPHARMA US LIMITED

03
Address
2440 RESEARCH BLVD, SUITE 400
ROCKVILLE, MD 20850

Ownership History

I-MAB

Original Applicant
03
George Town KY

I-MAB

Owner at Publication
03
George Town KY

I-MAB

Original Registrant
03
George Town KY

I-MAB BIOPHARMA CO., LTD

New Owner After Registration #1
03
SHANGHAI CN

I-MAB BIOPHARMA US LIMITED

New Owner After Registration #2
03
ROCKVILLE, MD

Legal Representation

Attorney
Jacqueline Lesser

USPTO Deadlines

Next Deadline
244 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200901)
Due Date
September 01, 2026
Grace Period Ends
March 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Dec 1, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 1, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 1, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 1, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 16, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 16, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 16, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 16, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 25, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 17, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 1, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 31, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 30, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 29, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 14, 2020 IUAF S USE AMENDMENT FILED Loading...
Jul 29, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 14, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 16, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 19, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 19, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 18, 2020 ALIE A ASSIGNED TO LIE Loading...
Mar 10, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 24, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 24, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 12, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 10, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 23, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders
First Use Anywhere: Apr 13, 2020
First Use in Commerce: Apr 28, 2020

Additional Information

Design Mark
The mark consists of a stylized ring having a blue and dark blue left portion and a green and light green right portion. The color white appearing in the mark represents transparent space and is not a feature of the mark.
Color Claim
The color(s) blue, dark blue, green, and dark green is/are claimed as a feature of the mark.

Classification

International Classes
005